Impact of multimodality therapy in esophageal cancer on disease, patient and treatment KU Leuven
Multimodality treatment in potentially curable locally advanced esophageal cancer (EC) and cancer of the gastro-esophageal junction (GEJC) is standard practice in most patients because it is improving local control and survival in the majority of patients. We hypothesize that multimodality treatment in these patients is not always synonym of improved outcome compared to primary surgery on one hand, but on the other hand, multimodality treatment ...